Steadfast Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Steadfast Capital Management's BSX Position: Q3 2025 in Review
Steadfast Capital Management sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 1,096,590 shares — an estimated $118M sold.
Steadfast Capital Management first reported a position in BSX in Q1 2020 and held it in 15 quarters. The position peaked at $362M in Q3 2020. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.
- Steadfast Capital Management reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
- Steadfast Capital Management sold 1,096,590 Boston Scientific shares in Q3 2025, an estimated $118M.
- Steadfast Capital Management first reported a position in Boston Scientific in Q1 2020 and held it in 15 quarters.
- Steadfast Capital Management's Boston Scientific position peaked at $362M in Q3 2020.
- 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.
Based on Steadfast Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.